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1144-132 L-Type Calcium Channel Inhibitor Diltiazem Prevents 
Diastolic Dysfunction and Stress-Induced Cardiac 
Decompensation and Death in a Mouse Model of 
Familial Hypertrophic Cardiomyopathy
Dirk Westermann, Björn Knollmann, Heinz-Peter Schultheiss, Paul Steendjik, Carsten 
Tschoepe, Charité University Medical Center, Berlin, Germany, Georgetown University 
Medical Center, Georgetown, WA
The cardiac troponin T (TnT) I79N mutation has been linked to familial hypertrophic car-
diomyopathy (FHC) and a high incidence of sudden death. To investigate the effect of this
mutation on left ventricular (LV) function, we determined LV pressure-volume (PV) rela-
tionships in transgenic mice expressing human wild type (Wt) and human mutant TnT
(I79N). A micro-conductance catheter was introduced in the LV (n =8/group). Loadinde-
pendent enddiastolic PV relationships were obtained (EDPVR) under basal and stress
conditions (0.25 mg/kg isoproterenol i.p.). After treatment with the calcium channel inhib-
itor diltiazem we investigated the LV function in another set of I79N mice.
Basal conditions: I79N mice showed increased systolic function compared to Wt :
EF:63.3±.4.3* vs. 51.1±5.0%; SV:35±3.2* vs. 27.1±1.6µl; CO: 16950±1300* vs.
12119±1027µl/min; * p<0.05 without differences in HR and LVP. Load dependent dias-
tolic pressure indices as LVEDP were unchanged, but the load independent EDPVR was
increased (0.5±0.1* vs. 0.3±0.03; * p<0.05), showing increased LV stiffness leading to a
diastolic dysfunction.
Stress conditions: HR (654±21 vs. 625±25 bpm) and LVP (159.9±8.6 vs.
169.5±11.3mmHg; p<0.05) response was similar in all groups, but systolic function of
I79N mice decreased compared to Wt (EF: 25.1±5.5* vs. 51.7±8.4%; SV: 14.0±3.3* vs.
22.17±4.4µl; CO: 8916±1832* vs. 13915±1558µl/min; Ves: 42.2±3.6* vs. 25.8±5.6µl
*p<0.05). Diastolic indices demonstrate diastolic dysfunction in I79N compared to Wt:
(LVEDP: 17.1±2.2* vs. 8.4±2.2mmHg; *p<0.05). This cardiac decomensation due to
stress conditions leads to death in all I79N, but in none of the Wt animals.
Diltiazem prevented the reduction in SV, EF, CO and the rise in LVEDP without affecting
HR signifcantly compared to non treated I79N and decreased mortality due to stress to
25 %.
I79N mice show an increased cardiac stiffness under basal conditions, and a diastolic
dysfunction leading to decompensation and death under stress. Diltiazem prevents car-
diac decompensation and death. These data gain an inside into hemodynamic pathology
of the I79N mutation leading to FHC and why sudden death is common in FHC.
1144-133 β3-adrenergic Receptor Activation Decreases Peripheral 
Vascular Resistance in Heart Failure by Restoring 
Endothelial Dependent Vasorelaxation via Endothelial 
Nitric Oxide Synthase Upregulation
Hoang M. Thai, Bao Do, Raymond Huang, Peter Spooner, Julia Indyk, Steve Goldman, 
Mohamed Gaballa, Southern Arizona VA Health Care System, Tucson, AZ, Sarver Heart 
Center at The Univeristy of Arizona, Tucson, AZ
Background:Peripheral vascular resistance (PVR) is increased in heart failure (HF).
Therapy designed to decrease PVR by restoring nitric oxide (NO) mediated endothelial
dependent (ED) vasorelaxation may prove to be vital in improving survival. Recent data
suggests that beta-3 adrenoreceptor (β3-AR) activation may increase NO bioavailability.
This study was performed to evaluate whether β3-AR activation with BRL, a β3-AR ago-
nist, decreases PVR via NO mediated ED vasorelaxation in HF.
Methods: Sprague-Dawley rats with HF after coronary artery ligation were randomized
into untreated controls and BRL treatment. After four weeks of therapy, hemodynamics
was obtained and aortic vasorelaxation in response to isoproterenol with and without L-
NMMA were performed. Additionally, bovine pulmonary artery endothelial cells in culture
were incubated for 24 hours with BRL at 10 µM and 20 µM concentrations. Western blots
for endothelial NO synthase (eNOS) protein concentration was performed.
Results: In HF rats treated with BRL, heart rate, systolic blood pressure, and left ventric-
ular (LV) dP/dt was decreased (P<0.05) compared to untreated HF rats. LV end diastolic
pressure (LVEDP) was unchanged. BRL significantly improved endothelial dependent
vasorelaxation (37.1 ± 15.3 versus 17.3 ± 6.8 %, P<0.05) compared to untreated HF rats
at peak isoproterenol dose. Addition of L-NMMA completely blunted all vasorelaxation
responses. Bovine cell cultures incubated with BRL resulted in greater (P<0.05) than two
fold increases of eNOS compared to untreated cell cultures.
Conclusions: β3-AR activation decreases peripheral vascular resistance in heart failure
by restoring endothelial dependent vasorelaxation via endothelial nitric oxide synthase
upregulation.
1144-134 Direct Comparison of Bone Marrow Stromal Versus 
Mononuclear Cells in Murine Cardiac Function After 
Cellular Cardiomyoplasty
Yoshihisa Morimoto, Igor Klem, Enrikas Vainorius, Brad S. Sutton, Bryce H. Davis, 
Robert M. Judd, Doris A. Taylor, Duke University Medical Center, Durham, NC
Background: Cellular cardiomyoplasty, transplantation of bone marrow cells into injured
myocardium, has been reported to improve cardiac function but the mechanism is
unknown. Thus, in a mouse cryoinjury model, we compared the functional effects of
potentially myogenic bone marrow stromal cells (BM), potentially angiogenic bone mar-
row mononuclear cells (MNC), or media alone (sham) with historical myoblast (Mb) con-
trols where myogenesis is clear. Methods: C57BL/6 mice (n=6, each group) were
subjected to LV cryoinfarction. Animals received myocardial injections of 107 BM, MNC or
media 7 days after injury. Contiguous short-axis (2mm) ECG-gated segmental FLASH
images were acquired on a 1.5T clinical scanner (eyecoil) immediately before, and again
4 wks after injection. Result: After infarction, all animals showed poor ejection fraction
(EF, %) (57±11 in BM, 56±8 in MNC and 60±16 in sham) and all infarction areas were
detectable. At 4 wks EF was improved in BM (61±20) and MNC (62±14) similar to Mb, yet
deteriorated in the sham group (56±8). Conclusions: Although both MNC and BM cells
stabilize cardiac function to a similar degree as myoblasts, histological evidence sug-
gests differing mechanisms of angiogenesis versus myogenesis, respectively. 
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1145-115 Congestive Heart Failure in Rheumatoid Arthritis 
Patients: Rates, Predictors, and the Effect of Antitumor 
Necrosis Factor Therapy
Frederick Wolfe, Kaleb Michaud, Alan Mendelsohn, Arthritis Research Center 
Foundation, Wichita, KS, Centocor, Inc., Malvern, PA
Background: Cardiovascular morbidity (e.g. pericarditis, diastolic dysfunction) is
increased in rheumatoid arthritis (RA) patients though data on rates of congestive heart
failure (CHF) in RA patients is unknown. Elevated tumor necrosis factor (TNF-alpha) lev-
els have been identified as potential factors in CHF development. However, clinical stud-
ies have demonstrated limited value of anti-TNF blockade in patients with CHF. This
study examined background CHF risk factors in RA and osteoarthritis (OA) patients, CHF
prevalence and incidence rates in RA patients, and evaluated the relationship of anti-TNF
agents and rates of CHF. Methods: Cohorts of RA patients (n = 13,171) and OA patients
(n=2,568) in a longitudinal outcome study of the National Data Bank for Rheumatic Dis-
eases were assessed via questionnaire and medical record review for CHF during a two-
year period ending in 6/2002. Propensity scores were used to adjust for the risk of anti-
TNF prescription. Results: Adjusted prevalence of CHF in RA patients was increased
over that in OA patients (3.9% vs. 2.2%). CHF risk factors (e.g., hypertension, prior MI,
diabetes, advanced age) were similar between RA and OA patients though measures of
RA severity (HAQ, education, weight) were contributory to CHF rates. Adjusted rates of
CHF were lower in anti-TNF treated RA patients (n = 5,832) than in non anti-TNF RA
treated patients (2.8% vs. 3.9%, average treatment effect –1.2%[-1.9 to -0.5]). The rate of
new-onset incident cases was low (0.2%) and unrelated to anti-TNF therapy. Conclu-
sion: In 13,171 RA patients, rates of CHF were increased compared to concomitant OA
patients. Non-RA factors predicting CHF are the same in RA patients as in patients from
general population studies, but RA activity/severity measures also predicted heart failure.
Patients receiving anti-TNF therapy had lower rates of prevalent CHF compared to non
anti-TNF treated patients. Incidence rates of CHF were low and unrelated to treatment.
1145-116 Prevalence and Mechanism of Functional Mitral 
Regurgitation in Dilated Cardiomyopathy: Baseline Data 
From the Acorn Trials
Seung Woo Park, Spencer Kubo, Mariell Jessup, Steven Bolling, Michael Acker, Jae K. 
Oh, Mayo Clinic, Rochester, MN, Acorn Cardiovascular Inc., St. Paul, MN
Background: Functional mitral regurgitation (MR) in dilated cardiomyopathy has signifi-
cant prognostic implication, but its mechanism needs to be elucidated. The aim of the
study was to determine the prevalence and the main echocardiographic factors determin-
ing the severity of MR in theses patients. Method: From the baseline echocardiographic
results of Acorn cardiac support device trials, 154 patients with dilated cardiomyopathy
without organic mitral valve disease were identified. Echocardiographic parameters were
correlated with the severity of MR assessed by color flow imaging. Results: There were
96 males and the mean age was 55 ± 12 years. Mitral regurgitation was detected in 111
patients (72%); 29 in grade I (26%), 22 in grade II (20%), 29 in grade III (26%), and 31 in
grade IV (28%). In univariate analysis, systolic and diastolic left ventricular dimensions
(p<0.01), systolic and diastolic spherical indices of left ventricle (p<0.0005), systolic and
diastolic mitral annulus size and area (p<0.0001), left atrial area and volume (p<0.0001),
tethering distance from papillary muscle to annulus fibrosa (p<0.0001), tenting height
(p<0.0001) and tenting area (p<0.0001) of mitral valve, and stroke volume (p<0.005)
showed significant correlation with the severity of MR. Left ventricular volume or ejection
fraction did not show significant correlation. In multivariate analysis, only tenting area
showed significant correlation with severity of MR (p<0.0001). Conclusion: Functional
MR was found in more than two thirds of patients with dilated cardiomyopathy, and sever-
ity of MR was mainly related with the tenting area of the mitral valve. Therefore, treatment
interventions for functional MR may have to be directed to reduce the tenting area of
regurgitant valve in addition to reducing the size of the mitral annulus.
